Novo Nordisk A-S
Price & Volume
Stats
See more52W Range | $78.17-$147.59 |
Market Cap | $352.9B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $270.5B |
Revenue Growth (YoY) | 21.4% |
Gross Profit (12 Mos) | $229B |
Diluted EPS | $2.93 |
News
See moreYahoo Finance • 2 days ago
Jim Cramer’s Comments on Novo Nordisk A/S (NVO) Surrounded Its Weight Loss Drugs Being Picked For Medicare Price Negotiations
Yahoo Finance • last month
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
Yahoo Finance • 3 months ago
What can't Ozempic and other weight loss drugs cure?
Yahoo Finance • 3 months ago
Novo Nordisk A/S - share repurchase programme
About
CEO | Mr. Lars Fruergaard Jorgensen |
CFO | Mr. Karsten Munk Knudsen |
Address | Novo Alle 1, Bagsvaerd, Denmark, 2880 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 71,880 |
